Works matching IS 03407004 AND DT 2000 AND VI 49 AND IP 10
Results: 6
Targeting of cancer cells with monoclonal antibodies specific for C3b(i).
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 10, p. 551, doi. 10.1007/s002620000140
- By:
- Publication type:
- Article
Granulocyte/macrophage-colony-stimulating factor augments lymphokine-activated killer activity from lymphocytes via macrophages in lung cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 10, p. 537, doi. 10.1007/s002620000144
- By:
- Publication type:
- Article
The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 10, p. 517, doi. 10.1007/s002620000145
- By:
- Publication type:
- Article
Generation and functional characterisation of dendritic cells from patients with pancreatic carcinoma with special regard to clinical applicability.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 10, p. 544, doi. 10.1007/s002620000149
- By:
- Publication type:
- Article
Regulation of CD40L expression on natural killer cells by interleukin-12 and interferon γ: its role in the elicitation of an effective antitumor immune response.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 10, p. 563, doi. 10.1007/s002620000151
- By:
- Publication type:
- Article
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 10, p. 530, doi. 10.1007/s002620000150
- By:
- Publication type:
- Article